CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
PlateLys aims to develop a human-based serum substitute for cell culture, eliminating the need for animal-derived serum. This innovative product enhances patient safety and supports the growing field of cellular therapies by providing a reliable and standardized growth factor source.
Cellular therapies making use of stem cells, engineered immune cells or engineered tissue represent an unprecedented and fast-growing therapeutic area.
To date, 14 cell therapies have been approved by the FDA.
However, the cells being implanted to the patient need to be cultured in vitro at some point under highly specific and controlled conditions.
One of these conditions –indispensable to culture any type of isolated cell in vitro– involves using animal-derived serum as a source of hormones an…
PLATOME LIFTAEKNI EHF
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
